Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min.

Autor: Lisa L Ross, A Sarah Walker, Yu Lou, Allan R Tenorio, Diana M Gibb, Julia Double, Charles Gilks, Cynthia C McCoig, Paula Munderi, Godfrey Musoro, Cissy M Kityo, Heiner Grosskurth, James Hakim, Peter N Mugyenyi, Amy Cutrell, Teodora Perger, Mark S Shaefer

Publikováno v: PLoS ONE, Vol 14, Iss 11, p e0225199 (2019)

A retrospective analysis of the randomized controlled DART (Development of AntiRetroviral Therapy in Africa; ISRCTN13968779) trial in HIV-1-positive adults initiating antiretroviral therapy with co-formulated zidovudine/lamivudine plus either tenofov

Externí odkaz: https://doaj.org/article/e579cd919b1743ad8e3d3009fb5a674a

Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): A Feasibility Trial of Nicotine Vaping Products for Smoking Cessation Among People Living with HIV

Autor: Stephanie Edwards, Cheneal Puljević, Judith A. Dean, Charles Gilks, Mark A. Boyd, Peter Baker, Peter Watts, Chris Howard, Coral E. Gartner

Publikováno v: AIDS and behavior.

People living with HIV (PLHIV) have high rates of tobacco smoking. Nicotine vaping products (NVPs) may promote tobacco smoking cessation and/or harm reduction. This study aimed to trial the feasibility of NVPs for promoting tobacco smoking cessation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b58379b1ab57c01cf485206678b44c7
https://pubmed.ncbi.nlm.nih.gov/35869375

Discussion

Autor: Anthony Mbewu, Richard Feachem, Ariel Pablos-Mendez, Charles Gilks, Carla AbouZahr, Tomris Türmen

Publikováno v: Bulletin of the World Health Organization, Vol 79, Iss 12, Pp 1145-1151 (2001)

Externí odkaz: https://doaj.org/article/14c5731e7f614edfa84059bd33db4802

CD8+ T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4+ T Cells

Autor: Jennifer Serwanga, Susan Mugaba, Auma Betty, Edward Pimego, Sarah Walker, Paula Munderi, Charles Gilks, Frances Gotch, Heiner Grosskurth, Pontiano Kaleebu

Publikováno v: AIDS Research and Treatment, Vol 2011 (2011)

Objective. To better understand attributes of ART-associated HIV-induced T-cell responses that might be therapeutically harnessed. Methods. CD8+ T-cell responses were evaluated in some HIV-1 chronically infected participants of the fixed duration STI

Externí odkaz: https://doaj.org/article/c1a6d59df54e466aba9361f334649418

She knows that she will not come back: tracing patients and new thresholds of collective surveillance in PMTCT Option B+

Autor: Janet Seeley, Charles Gilks, Fabian Cataldo, Susan Hoskins, Annabelle South, Misheck Julian Nkhata, Margaret Thomason, Diana Gibb

Publikováno v: BMC Health Services Research, Vol 18, Iss 1, Pp 1-10 (2018)
BMC health services research, 2018, Vol.18(1), pp.76 [Peer Reviewed Journal]
BMC Health Services Research

Background Malawi, Uganda, and Zimbabwe have recently adopted a universal ‘test-and-treat’ approach to the prevention of mother-to-child transmission of HIV (Option B+). Amongst a largely asymptomatic population of women tested for HIV and immedi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2998919bba66569e3d56a5d01a48bfad
https://doi.org/10.1186/s12913-017-2826-7